Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mebendazole + Quinfamide for Intestinal Helminthiasis and Amebiasis
NCT02385058Phase 4Completed
- Sponsor
- Janssen-Cilag
- Start
- Oct 2005
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mebendazole, quinfamide in intestinal helminthiasis, amebiasis, sponsored by Janssen-Cilag. Started Oct 2005; status: completed.
02
Drugs
mebendazolequinfamide
03
Conditions
intestinal helminthiasisamebiasis
Beyond the preview
Go deeper on NCT02385058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02385058.